Does MDD (Medical Devices Directive) review offer opportunity for simplify health technology directives?
This article was originally published in Clinica
Executive Summary
A single EU healthcare products directive is needed in a "new Europe that deserves a new Directive with new vision". That is the view of Neil R Armstrong, CEO of Meddiquest in the light of the draft Commission proposal revising the Medical Devices Directive (MDD), the deadline for which (June 25) is about to expire.
You may also be interested in...
Common Regulatory Starting Point Means EU-UK Are On Track For Medtech MRA, Say German Firms
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
COVID-19 Vaccines Donated To Philippines Require Emergency Use Authorization
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: